See also this year's filing and all EDGAR filings for this company.
PDF Report 0001502152_2023_GlobeStar_Therapeutics_Corp.pdf
Logs
warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001502152', 'EntityCommonStockSharesOutstanding': 770360616, 'Assets': 9915, 'AssetsCurrent': 9915, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 1204475, 'LiabilitiesAndStockholdersEquity': 9915, 'LiabilitiesCurrent': 1204475, 'LiabilitiesNoncurrent': 0, 'NetIncome': -1487810, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': -1194560, 'remainder_NetIncome': -1487810, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001502152')"} |